Where does Hospices Civils DE Lyon rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Hospices Civils DE Lyon ranks #7,857 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Hospices Civils DE Lyon hold?

Hospices Civils DE Lyon holds 41 US utility patents granted between 2015 and 2025, spanning 23 technology areas.

What is Hospices Civils DE Lyon's Innovation Score?

Hospices Civils DE Lyon has an Innovation Score of 43.3 out of 100 (top 28% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Hospices Civils DE Lyon focus on?

Hospices Civils DE Lyon's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 19 patents, ranking #797 of 7,863 assignees active in that subclass. Grants appear in 23 CPC subclasses total.

Is Hospices Civils DE Lyon's patent grant rate increasing or decreasing?

Hospices Civils DE Lyon's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Hospices Civils DE Lyon's patents?

Hospices Civils DE Lyon's patents average 13.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Hospices Civils DE Lyon patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Hospices Civils DE Lyon

USPTO PatentsView assignee record - 41 granted patents across 23 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Hospices ranks #7,857 of 49,997 tracked US assignees by granted-patent volume, with 41 patents across 23 technology areas.

#7,857
of 49,997 US assignees by volume: Top 28%
by Innovation Score (43.3/100): 13.0
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7857 · Foreign Corporation #7,857 · 41 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 41 grants
UPPER-Q #7,857/49,997
PHOTO-FINISH GemVax & Kael
CPC-FOCUS G01N · 23 areas
INNOV-PAR 43.3/100
CLAIMS-RICH 13.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: GemVax & Kael Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Hospices’s 43.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.9 pts (30%) Velocity 5.6 pts (13%) Breadth 17.0 pts (39%) Claim depth 7.8 pts (18%)

Qualcomm Incorporated · highest

85
Draka Comteq B V · near

43
HighRes Biosolutions · near

43
Hong ANN Tool… · near

43
Hood Technology · near

43
Hospices Civils DE… · this assignee

43
3D Lighting… · lowest

7

What this shows Hospices's Innovation Score is 43.3/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Hospices?

Each dot is one of Hospices’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Hospices’s own 13.0 claims/patent is ABOVE the 12.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Hospices vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Hospices's grants concentrate

Hospices Civils DE Lyon is a focused PatentsView assignee: 23 CPC subclasses with 46.3% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2022 (7 grants) versus a trough of 1 in 2024. By volume, Hospices sits between GemVax & Kael Co., Ltd. and Institute OF Physics, THE Chinese Academy OF Sciences.

Hospices's three-year grant acceleration

Hospices Civils DE Lyon shows 11 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Gemvax & Kael

41
Halo Internationa…

41
Hamilton Sundstra…

41
Hefei BOE Display…

41
Honeywell

41
Huami

41
Inha University R…

41
Institute OF Phys…

41
Hospices Civils D… ◀

41

What this shows Hospices holds 41 patents at rank #7,856, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Hospices

By rank, the assignees closest to #7,856 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Hospices's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Hospices, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Hospices ranks #797 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Hood Technology Corporation 43 Draka Comteq B.V. 43 HighRes Biosolutions, Inc. 43 Hong ANN Tool Industries Co., Ltd. 43

Hospices's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 28% higher than 72% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Hospices Civils DE Lyon patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	7.3%
2016	4	9.8%
2017	5	12.2%
2018	4	9.8%
2019	4	9.8%
2020	6	14.6%
2021	3	7.3%
2022	7	17.1%
2023	3	7.3%
2024	1	2.4%
2025partial year	1	2.4%

Which technologies does Hospices Civils DE Lyon patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 19

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 14

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 10

C07K - Peptides 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

A61B - DIAGNOSIS; SURGERY; Identification 5

C07D - Heterocyclic Compounds 3

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 2

B29B - Preparation OR Pretreatment OF THE Material TO BE SHAPED; Making Granules OR PREFORMS; Recovery OF Plastics OR Other Constituents OF Waste Material Containing Plastics 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

C07C - Acyclic OR Carbocyclic Compounds 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

Top 15 of 23 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Hospices Civils DE Lyon's patent record in context - here's where to go next.

Hospices Civils DE Lyon's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 46.3% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #7,857 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Hospices Civils DE Lyon against GemVax & Kael Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.